Kenneth W. O'Keefe
Director · Jazz Pharmaceuticals plc
Individual
- 2025
- Dec 4, 2025
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Kenneth W. O'Keefe files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Bruce C. Cozadd - $27.78M in JAZZ purchases and sales in the last 12 months
- Robert Iannone - $20.41M in JAZZ purchases and sales in the last 12 months
- Neena M. Patil - $11.50M in JAZZ purchases and sales in the last 12 months
- Patricia Carr - $1.66M in JAZZ purchases and sales in the last 12 months
- Rick E. Winningham - $1.66M in JAZZ purchases and sales in the last 12 months
- Samantha Pearce - $1.63M in JAZZ purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Kenneth W. O'Keefe?
Kenneth W. O'Keefe is a corporate insider, tracked as Director of Jazz Pharmaceuticals plc (JAZZ). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Kenneth W. O'Keefe last file a Form 4?
The most recent primary Form 4 on record is dated 4 December 2025, one of 2 filings going back to 2025.
